These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

461 related items for PubMed ID: 14993781

  • 1. Glycogen synthase kinase-3beta is involved in the process of myocardial hypertrophy stimulated by insulin-like growth factor-1.
    Seimi SK, Seinosuke K, Tsuyoshi S, Tomomi U, Tetsuaki H, Miki K, Ryuji T, Kenji I, Mitsuhiro Y.
    Circ J; 2004 Mar; 68(3):247-53. PubMed ID: 14993781
    [Abstract] [Full Text] [Related]

  • 2. Proteomic identification of 14-3-3zeta as an adapter for IGF-1 and Akt/GSK-3beta signaling and survival of renal mesangial cells.
    Singh LP, Jiang Y, Cheng DW.
    Int J Biol Sci; 2006 Oct 27; 3(1):27-39. PubMed ID: 17200689
    [Abstract] [Full Text] [Related]

  • 3. Protein breakdown in muscle from burned rats is blocked by insulin-like growth factor i and glycogen synthase kinase-3beta inhibitors.
    Fang CH, Li BG, James JH, King JK, Evenson AR, Warden GD, Hasselgren PO.
    Endocrinology; 2005 Jul 27; 146(7):3141-9. PubMed ID: 15802492
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Anti-hypertrophic effect of NHE-1 inhibition involves GSK-3beta-dependent attenuation of mitochondrial dysfunction.
    Javadov S, Rajapurohitam V, Kilić A, Zeidan A, Choi A, Karmazyn M.
    J Mol Cell Cardiol; 2009 Jun 27; 46(6):998-1007. PubMed ID: 19318234
    [Abstract] [Full Text] [Related]

  • 6. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
    Desbois-Mouthon C, Blivet-Van Eggelpoël MJ, Beurel E, Boissan M, Delélo R, Cadoret A, Capeau J.
    Hepatology; 2002 Dec 27; 36(6):1528-36. PubMed ID: 12447879
    [Abstract] [Full Text] [Related]

  • 7. GSK-3beta negatively regulates skeletal myotube hypertrophy.
    Vyas DR, Spangenburg EE, Abraha TW, Childs TE, Booth FW.
    Am J Physiol Cell Physiol; 2002 Aug 27; 283(2):C545-51. PubMed ID: 12107064
    [Abstract] [Full Text] [Related]

  • 8. Urocortin-induced cardiomyocytes hypertrophy is associated with regulation of the GSK-3β pathway.
    Gruson D, Ginion A, Decroly N, Lause P, Vanoverschelde JL, Ketelslegers JM, Bertrand L, Thissen JP.
    Heart Vessels; 2012 Mar 27; 27(2):202-7. PubMed ID: 21505854
    [Abstract] [Full Text] [Related]

  • 9. Glycogen synthase kinase-3beta plays a pro-apoptotic role in beta-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes: Role of beta1 integrins.
    Menon B, Johnson JN, Ross RS, Singh M, Singh K.
    J Mol Cell Cardiol; 2007 Mar 27; 42(3):653-61. PubMed ID: 17292911
    [Abstract] [Full Text] [Related]

  • 10. Alleviating the suppression of glycogen synthase kinase-3beta by Akt leads to the phosphorylation of cAMP-response element-binding protein and its transactivation in intact cell nuclei.
    Salas TR, Reddy SA, Clifford JL, Davis RJ, Kikuchi A, Lippman SM, Menter DG.
    J Biol Chem; 2003 Oct 17; 278(42):41338-46. PubMed ID: 12900420
    [Abstract] [Full Text] [Related]

  • 11. Endogenous IGF-I protects human intestinal smooth muscle cells from apoptosis by regulation of GSK-3 beta activity.
    Kuemmerle JF.
    Am J Physiol Gastrointest Liver Physiol; 2005 Jan 17; 288(1):G101-10. PubMed ID: 15297258
    [Abstract] [Full Text] [Related]

  • 12. Insulin-like growth factor-I inhibits dexamethasone-induced proteolysis in cultured L6 myotubes through PI3K/Akt/GSK-3beta and PI3K/Akt/mTOR-dependent mechanisms.
    Li BG, Hasselgren PO, Fang CH.
    Int J Biochem Cell Biol; 2005 Oct 17; 37(10):2207-16. PubMed ID: 15927518
    [Abstract] [Full Text] [Related]

  • 13. Role of connexin-43 in protective PI3K-Akt-GSK-3β signaling in cardiomyocytes.
    Ishikawa S, Kuno A, Tanno M, Miki T, Kouzu H, Itoh T, Sato T, Sunaga D, Murase H, Miura T.
    Am J Physiol Heart Circ Physiol; 2012 Jun 15; 302(12):H2536-44. PubMed ID: 22505645
    [Abstract] [Full Text] [Related]

  • 14. Arrest of human lung fibroblasts in G2 phase after irradiation is regulated by converging phosphatidylinositol-3 kinase and beta1-integrin signaling in vitro.
    Cordes N, van Beuningen D.
    Int J Radiat Oncol Biol Phys; 2004 Feb 01; 58(2):453-62. PubMed ID: 14751515
    [Abstract] [Full Text] [Related]

  • 15. Protective effect of proanthocyanidins on anoxia-reoxygenation injury of myocardial cells mediated by the PI3K/Akt/GSK-3β pathway and mitochondrial ATP-sensitive potassium channel.
    Hu Y, Li L, Yin W, Shen L, You B, Gao H.
    Mol Med Rep; 2014 Oct 01; 10(4):2051-8. PubMed ID: 25109283
    [Abstract] [Full Text] [Related]

  • 16. Atorvastatin inhibits GSK-3beta phosphorylation by cardiac hypertrophic stimuli.
    Planavila A, Rodríguez-Calvo R, Palomer X, Coll T, Sánchez RM, Merlos M, Laguna JC, Vázquez-Carrera M.
    Biochim Biophys Acta; 2008 Oct 01; 1781(1-2):26-35. PubMed ID: 18036354
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of glycogen synthase kinase-3beta activity is sufficient to stimulate myogenic differentiation.
    van der Velden JL, Langen RC, Kelders MC, Wouters EF, Janssen-Heininger YM, Schols AM.
    Am J Physiol Cell Physiol; 2006 Feb 01; 290(2):C453-62. PubMed ID: 16162663
    [Abstract] [Full Text] [Related]

  • 18. Glycogen synthase kinase-3 couples AKT-dependent signaling to the regulation of p21Cip1 degradation.
    Rössig L, Badorff C, Holzmann Y, Zeiher AM, Dimmeler S.
    J Biol Chem; 2002 Mar 22; 277(12):9684-9. PubMed ID: 11779850
    [Abstract] [Full Text] [Related]

  • 19. [The regulation of Akt signaling on axonal density after hypoxic-ischemic brain injury in neonatal rat].
    Xiong T, Chen HJ, Qu Y, Luo BR, Mu DZ.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Mar 22; 44(2):274-9. PubMed ID: 23745271
    [Abstract] [Full Text] [Related]

  • 20. Insulin and IGF-I stimulate the formation of the eukaryotic initiation factor 4F complex and protein synthesis in C2C12 myotubes independent of availability of external amino acids.
    Shen WH, Boyle DW, Wisniowski P, Bade A, Liechty EA.
    J Endocrinol; 2005 May 22; 185(2):275-89. PubMed ID: 15845920
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.